[HTML][HTML] KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer

SM Singel, C Cornelius, E Zaganjor, K Batten… - Neoplasia, 2014 - Elsevier
Despite evidence that kinesin family member 14 (KIF14) can serve as a prognostic
biomarker in various solid tumors, how it contributes to tumorigenesis remains unclear. We …

The neutrophil to albumin ratio as a predictor of pathological complete response in rectal cancer patients following neoadjuvant chemoradiation

B Tawfik, AA Mokdad, PM Patel, HC Li… - Anti-Cancer …, 2016 - journals.lww.com
Pathological complete response (pCR) following neoadjuvant chemoradiotherapy (nCRT)
and total mesorectal excision (TME), in patients with locally advanced rectal cancer, occurs …

Reducing hospitalizations: Institution of outpatient infusional EPOCH-based chemotherapy at a safety net hospital

N Keshvani, M Hon, A Gupta, TJ Brown… - Journal of oncology …, 2019 - ascopubs.org
PURPOSE: EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and
doxorubicin)-based chemotherapy is traditionally administered inpatient because of its …

[HTML][HTML] Metastatic rectal cancer to the breast

HC Li, P Patel, P Kapur, S Huerta - Rare Tumors, 2009 - ncbi.nlm.nih.gov
Rectal cancer metastatic to the breast is an exceedingly rare event with around 15 cases
reported in the literature. A metastatic breast deposit from the rectum signifies diffuse …

MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab

N Sadeghi, HC Li - Annals of Hematology, 2018 - Springer
Dear Editor, We describe a 48-year-old woman who presented to our institution with
relapsed hairy cell leukemia (HCL). She was diagnosed with HCL at age 42 and was treated …

Reducing wait time between admission and chemotherapy initiation

A Gupta, J Li, B Tawfik, T Pham, S Pathak… - Journal of oncology …, 2018 - ascopubs.org
Purpose: Reducing the length of stay is a high-priority objective for all health care
institutions. Delays in chemotherapy initiation for planned preadmissions lead to patient …

Applying the'COST'(Culture, oversight, systems change, and training) framework to de-adopt the neutropenic diet

A Gupta, TJ Brown, S Singh, A Sen, D Agrawal… - The American Journal of …, 2019 - Elsevier
De-adoption is the discontinuation of ineffective, inefficient, unnecessary, or harmful health
care services that provide no additional benefit relative to their cost. 1, 2 Often, processes or …

Idelalisib-induced pneumonitis

A Gupta, HC Li - Case Reports, 2016 - casereports.bmj.com
A woman in her 40s with relapsed follicular lymphoma presented with a few days history of
shortness of breath and cough producing yellow sputum. There were no reported toxic …

Gemcitabine and platinum-based chemotherapy in metastatic breast cancer.

HC Li, CA Russell - Oncology (Williston Park, NY), 2004 - europepmc.org
Although anthracyclines and the taxanes comprise the most active first-line cytotoxic
treatments in patients with hormone-insensitive or life-threatening metastatic breast cancer …

Racial and Ethnic Disparities in Acute Myeloid Leukemia: 15-year Experience at a Safety Net Hospital System

S Dong, N Premnath, N Sadeghi, R Kainthla… - Leukemia Research, 2024 - Elsevier
Despite recent therapeutic advances, ethnic minorities in the US continue to have
disproportionately poor outcomes in many hematologic malignancies such as AML. We …